How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.

The loop takes agentic AI a step further, by authorizing a swarm of agents to work continuously in the background, endlessly.

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...

The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

Buffer overflow vulnerabilities have driven remote code execution for decades and keep appearing in critical network ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

Most research papers assume a human will read them first. However, Google DeepMind's latest sprawling 60-page look at the road from AGI to superintelligence doesn't bother with that pretense. Section ...

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...